baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Vericel Corp/ US92346J1088 /

25/10/2024 21:59:59	Chg. +0.87	Volume	Bid-	Ask-	High	Low
43.70USD	+2.03%	37,853 Turnover: 1.66 mill.	-Bid Size: -	-Ask Size: -	44.46	43.07

GlobeNewswire 29/08 Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024

GlobeNewswire 26/08 Vericel Announces FDA Approval and Commercial Availability of MACI Arthro

GlobeNewswire 15/08 Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Therm...

GlobeNewswire 14/08 MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update

GlobeNewswire 07/08 Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024

GlobeNewswire 01/08 Vericel Reports Second Quarter 2024 Financial Results

GlobeNewswire 22/07 Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer

GlobeNewswire 18/07 Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024

GlobeNewswire 11/06 Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024

GlobeNewswire 29/05 MediWound Reports First Quarter 2024 Financial Results and Provides Company Update

GlobeNewswire 22/05 Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 20...

GlobeNewswire 22/05 Invivyd Elects Two New Independent Members to its Board of Directors

GlobeNewswire 08/05 Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance

GlobeNewswire 24/04 Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024

GlobeNewswire 29/02 Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Fina...

GlobeNewswire 27/02 Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024

GlobeNewswire 15/02 Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024

GlobeNewswire 05/02 Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024

GlobeNewswire 09/01 Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results

GlobeNewswire 09/01 MediWound Announces that FDA has Accepted for Review the Supplement to the NexoBrid BLA to Include P...

GlobeNewswire 03/01 Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 20...

GlobeNewswire 28/12/2023 MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for...

GlobeNewswire 21/11/2023 MediWound Reports Third Quarter 2023 Financial Results and Provides Company Update

GlobeNewswire 08/11/2023 Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

GlobeNewswire 07/11/2023 Vericel to Present at the Stephens Annual Investment Conference

Vericel Corp/ US92346J1088 /

If you wish to receive reply to your feedback, please provide your email address.